发明名称 |
HUMAN LEUCINE-RICH A-2-GLYCOPROTEIN-1 AND AMINOPEPTIDASE N AS RISK INDICATORS FOR CANCER |
摘要 |
Diagnostic tests for characterizing a test subject's risk of developing or having cancer, based on determining the level of LRG1 and/or CD13 in a bodily sample obtained from a test subject are described. Levels of LRG1 and/or CD13 are then compared to a predetermined value that is derived from measurements of the levels of LRG1 and/or CD13 in comparable bodily samples obtained from control subjects. Such comparison characterizes the test subject's risk of developing or having cancer.
|
申请公布号 |
US2013102011(A1) |
申请公布日期 |
2013.04.25 |
申请号 |
US201213618005 |
申请日期 |
2012.09.14 |
申请人 |
ZHOU AIMIN;LIU HONGLI;ZENG CHUN;CLEVELAND STATE UNIVERSITY |
发明人 |
ZHOU AIMIN;LIU HONGLI;ZENG CHUN |
分类号 |
G01N33/68 |
主分类号 |
G01N33/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|